Silent myocardial damage in cocaine addicts

Heart

Volumn 97, Issue 24, 2011, Pages 2056-2062

  Aquaro, Giovanni Donato ^a   Gabutti, Alessandra ^a   Meini, Milo ^b   Prontera, Concetta ^a   Pasanisi, Emilio ^a   Passino, Claudio ^c   Emdin, Michele ^a   Lombardi, Massimo ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b Azienda USL 5   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GADOLINIUM PENTETATE; TROPONIN I;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART EDEMA; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SILENT MYOCARDIAL ISCHEMIA;

ADULT; CARDIOMYOPATHIES; COCAINE; COCAINE-RELATED DISORDERS; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING, CINE; MALE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR FUNCTION;

EID: 82255186391     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.226977     Document Type: Article

References (29)

1. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2010. United Nations Publication, 2010.
2. Phillips K, Luk A, Soor GS, et al. Cocaine cardiotoxicity. a review of the pathophysiology, pathology and treatment options. Am J Cardiovasc Drugs 2009;9:177-96.
3. Ramondo AB, Mistrorigo F, Angelini A. Intimal hyperplasia and cystic medial necrosis as substrate of acute coronary syndrome in a cocaine abuser: an in vivo/ex vivo pathological correlation. Heart 2009;95:82.
4. Virmani R, Robinowitz M, Smialek JE, et al. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 1988;115:1068-76.
5. Feldman JA, Fish SS, Beshansky JR, et al. Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med 2000;36:469-76.
6. Qureshi AI, Suri MF, Guterman LR, et al. Cocaine use and the likelihood of nonfatal myocardial infarction and stroke; data from the Third National Health and Nutrition Examination Survey. Circulation 2001;104:502-6. (Pubitemid 32116233)
7. Lucena J, Blanco M, Jurado C, et al. Cocaine-related sudden death: a prospective investigation in south west Spain. Eur Heart J 2010;31:318-29.
8. Robertson KE, Martin TN, Rae AP. Brugada-pattern ECG and cardiac arrest in cocaine toxicity: reading between the white lines. Heart 2010;96:643-4.
9. Wilson LD, Jeromin J, Garvey L, et al. Cocaine, ethanol and cocaethylene cardiotoxicity in an animal model of cocaine and ethanol abuse. Acad Emerg Med 2001;8:211-22. (Pubitemid 32201690)
10. Pavarin RM. Cocaine Consumpion and death risk: a follow-up study on 347 cocaine addicts in the metropolitan area of Bologna. Ann Ist Super Sanita 2008;44:91-8.
11. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940-65. (Pubitemid 39452612)
12. Beek AM, van Rossum AC. Use of cardiovascular magnetic resonance imaging in the assessment of left ventricular function, scar and viability in patients with ischaemic cardiomyopathy and chronic myocardial infarction. Heart 2010;96:1494-501.
13. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002;40:1531-4020.
14. Anon. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17:354-81.
15. Emdin M, Passino C, Prontera C, et al. A. Cardiac natriuretic hormones, neurohormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin Chem Lab Med 2004;42:627-36. (Pubitemid 38979140)
16. Maceira AM, Prasad SK, Khan M, et al. Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 2006;8:417-26.
17. Abdel-Aty H, Simonetti O, Friedrich MG. T2-Weighted Cardiovascular Imaging. J Magn Reson Imaging 2007;26:452-9.
18. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411-16. (Pubitemid 38679560)
19. Edwards NC, Routledge H, Steeds RP. T2-weighted magnetic resonance imaging to assess myocardial oedema in ischaemic heart disease. Heart 2009;95:1357-61.
20. Aquaro GD, Pingitore A, Masci PG, et al. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic Cardiomyopathy. Am J Cardiol 2010;105:392-7.
21. Aquaro GD, Positano V, Pingitore A, et al. Quantification of delayed enhancement in Hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010;12:21.
22. Soriano CJ, Ridocci F, Estornell J, et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005;45:743-8. (Pubitemid 40278973)
23. Buchholz S, Grieve SM, Maher R, et al. Cardiovascular flashlight. Cocaine-induced myocardial injury seen as multiple mid-wall foci of late enhancement by contrast-enhanced cardiac magnetic resonance imaging. Eur Heart J 2010;31:1422.
24. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age and Contractile Function. Circulation. 1999;100:1992-2002. (Pubitemid 29529292)
25. Aletras AH, Tilak GS, Natanson A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865-70. (Pubitemid 43739398)
26. Wilson LD, Henning RJ, Suttheimer C, et al. Cocaethylene causes dose-dependent reductions in cardiac function in anesthetized dogs. J Cardiovasc Pharmacol 1995;26:965-73.
27. Ren S, Tong W, Lai H, et al. Effect of long-term cocaine use on regional left ventricular function as determined by magnetic resonance imaging. Am J Cardiol 2006;97:1085-8.
28. Lossnitzer D, Steen H, Zahn A, et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis. J Cardiovasc Magn Reson 2010;12:47.
29. Raj V, Joshi S, Pennell DJ. Images in Cardiovascular Medicine. Cardiac magnetic resonance of acute myocarditis in an human immunodeficiency virus patient presenting with acute chest pain syndrome. Circulation 2010;121:2777-9.